The platform is tailored to convert brain’s neural activity into digital commands, eliminating the need for open-brain ...

Synchron announced today that it raised $200 million in a Series D financing round to support the commercialization of its ...

Avoidant/restrictive food intake disorder, or ARFID, can cause malnutrition and weight loss in children and adults even when ...

The federal government’s National Reconstruction Fund Corporation is “bringing an Australian company home”, investing $54m in ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

The convergence of AI, quantum computing, and biosciences is propelling the global healthcare industry into a new era - now ...

Within 24 hours of being hospitalized, a psychologist diagnosed Stella with avoidant/restrictive food intake disorder, or ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

Enterprises today are equipped with a vast array of tools and technologies. The opportunity lies in bringing these ...

Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s National Reconstruction Fund Corporation (NRFC) announced on Thursday.

Synchron was spun out of University of Melbourne by cofounders Dr Tom Oxley, Prof Nicholas Opie, and Dr Rahul Sharma in 2012.

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...